ILIAS Biologics Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of ILB-202 (NCT05843799) | ILIAS Biologics Inc. | 2023-05-16 |
Track ILIAS Biologics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.